坏死性下垂
金黄色葡萄球菌
细胞外
促炎细胞因子
微生物学
肿瘤坏死因子α
耐甲氧西林金黄色葡萄球菌
医学
肺炎
吞噬作用
细胞生物学
免疫学
生物
程序性细胞死亡
细菌
细胞凋亡
炎症
生物化学
内科学
遗传学
作者
Songjie Bai,Xuehuan Wen,Bingyu Li,Ruomeng Hu,Jie Yang,Qing Yu,Xianchang Zeng,Huajun Feng,Feng Zhu,Zhijian Cai,Gensheng Zhang
出处
期刊:Cell Reports
[Elsevier]
日期:2024-07-01
卷期号:43 (7): 114453-114453
标识
DOI:10.1016/j.celrep.2024.114453
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) infection, a major cause of hospital- and community-acquired pneumonia, still has a high mortality rate. Extracellular vesicles (EVs), as crucial mediators of intercellular communication, have a significant impact on infectious diseases. However, the role of EVs from alveolar macrophages (AMs) in MRSA pneumonia remains unclear. We report that AMs phagocytose MRSA and release more EVs in mice with MRSA pneumonia. EVs from AMs harboring phagocytosed MRSA exhibit significant proinflammatory effects and induce necroptosis by delivering tumor necrosis factor α (TNF-α) and miR-146a-5p. Mechanically, the upregulated miR-146a-5p in these EVs enhances the phosphorylation of RIPK1, RIPK3, and MLKL by targeting TNF receptor-associated factor 6 (TRAF6), thereby promoting TNF-α-induced necroptosis. The combination of a TNF-α antagonist and an miR-146a-5p antagomir effectively improves the outcomes of mice with MRSA pneumonia. Overall, we reveal the pronecrotic effect of EVs from MRSA-infected AMs and provide a promising target for the prevention and treatment of MRSA pneumonia.
科研通智能强力驱动
Strongly Powered by AbleSci AI